SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of Investors/Analyst call to be held on Friday, 25th July 2025 at 4.00P.M. to discuss the Company's financial results for the quarter ended June 30, 2025.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has scheduled a conference call with analysts and institutional investors on Friday, July 25, 2025, at 4:00 PM IST to discuss its financial results for the quarter ended June 30, 2025 (Q1 FY26). The call is a post-results engagement, meaning the quarterly numbers will already have been filed by then. The management line-up includes Founder & Non-Executive Director Arun Kumar, MD & CEO Sandeep Rao, and CFO Sarat Kumar. Dial-in numbers and a DiamondPass early-registration link have been shared for participants. This is a routine SEBI LODR disclosure under Regulation 30 and is meant for information and records.
This is a standard investor engagement event and not a material business update. The actual Q1 FY26 results — which are the real catalyst — are what shareholders should watch for during the call. Expect follow-on coverage from analysts on revenue, margins, and API business outlook.